Brought to you by 
Astex merges with metaGen in all-stock deal
03 Dec 2003
Executive Summary
MetaGen Pharmaceuticals GMBH (genomics-based technology for developing cancer therapeutics) is merging with structure-based drug discovery company Astex Technology Ltd. in a stock swap.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Nanotechnology, Chips, etc.
-
Large Molecule
- Antibodies
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com